Author Archives: MapleValle

You should be excited about this SCOTUS decision, too

You should be excited about this SCOTUS decision, too

By on 29 Jun 2015commentsShare

Amid big huzzahs for the Supreme Court ruling on gay marriage last week, there was another, less-heralded 5-4 vote that also deals a stiff blow to decades-old discriminatory practices: The court’s ruling on a Texas case involving housing discrimination.

On June 25, SCOTUS found that the Texas Department of Housing and Community Affairs violated the Fair Housing Act of 1968. The court cited the legal concept known as “disparate impact” — the idea that policies can still be discriminatory (and therefore illegal) even if the discrimination is not intentional. Disparate impact is an important concept in civil rights law, since proving intentional discrimination is extremely difficult in court. Disparate impact, however, per the New York Times’ take on the news, “can be proved using statistics.”

As Brentin Mock pointed out in January, while this particular case specifically addresses housing discrimination — the plaintiffs argued that state officials were sanctioning too many subsidized housing developments in African-American neighborhoods, perpetuating the very segregation they were meant to address — its outcome has huge ripple effects on environmental justice, too. Zoning laws, which are typically responsible for the siting of hazardous waste facilities and other polluting industries, can be called up under the Fair Housing Act. And showing the disproportionate impacts of pollution on low-income communities of color in court is far easier, Brentin wrote, than proving “there was malice in the heart of the developer who placed the housing projects near the landfills.”

Still, bloggers and analysts maintain, the court undermined its own historic ruling by limiting the ways that the disparate impact claim can be used. According to Quartz, for instance:

Unfortunately, the court tempered its own ruling by limiting disparate-impact claims to cases where a law or policy raises “artificial, arbitrary, and unnecessary barriers.” That gives lower courts a lot of leeway in interpretation. And it said that purely statistical evidence of disparate impact isn’t enough; plaintiffs must also prove that a law or policy caused that impact, which will often be hard.

So, this is hardly the end of the road. But now that the nation’s highest court has finally, officially recognized disparate impact, it should be far more possible to address real injustices that do exist — regardless of whether anybody intended them to.

Source:
The other big US Supreme Court Decision we should be celebrating is one no one’s talking about

, Quartz.

Justices Back Broad Interpretation of Housing Law

, New York Times.

Share

Please

enable JavaScript

to view the comments.

Find this article interesting?

Donate now to support our work.

Get Grist in your inbox

Read original article – 

You should be excited about this SCOTUS decision, too

Posted in Anchor, FF, GE, LAI, LG, ONA, PUR, Radius, Uncategorized | Tagged , , , , , , , , , | Comments Off on You should be excited about this SCOTUS decision, too

Doctors Aren’t Really Very Smart About Buying Generics

Mother Jones

<!DOCTYPE html PUBLIC “-//W3C//DTD HTML 4.0 Transitional//EN” “http://www.w3.org/TR/REC-html40/loose.dtd”>

Sarah Kliff takes a look today at our use of generic drugs. Long story short, it’s surprising how few of us save money by buying generic pain medicine instead of name brands (Advil, Tylenol, Bayer, etc.). Why? In most cases, I suppose it’s just ignorance: people don’t realize that the “store brand” is genuinely identical to the name brand. In other cases it might be something else. I buy generic ibuprofen, and it usually comes in the form of small brown pills. One day, however, I went to to a different drug store to stock up, and it turned out that their generic ibuprofen came in the form of small orange pills. Marian used these for a while, but really hated them. Eventually she cracked, and insisted on buying a new bottle from our usual drug store. Sometimes little things can make all the difference.

Anyway. The main point of Kliff’s post is that generics are good, and as evidence of this she puts up a chart showing what doctors themselves buy. Here’s an excerpt from the chart:

It’s true that doctors mostly favor generics when it comes to basic pain relievers. But frankly, what’s amazing to me is how little they prefer them. For chrissake, they prefer generic aspirin by only ten percentage points. That means they buy the name brand about 45 percent of the time. Why would a doctor do this? Granted, the extra few dollars is probably no big deal to them, but why waste it anyway? Certainly not because of ignorance. Are their spouses doing the buying? Or what?

And why the active preference for name-brand rubbing alcohol, of all things? It’s hard to think of anything more generic than that. What’s the deal here?

As for Alka-Seltzer, the dislike of generics is so huge that there just has to be some real difference here. But what?

In any case, I suspect this might have some real importance beyond the question of doctors spending a few dollars they don’t have to. If physicians aren’t really sold on generics in their own personal lives, does this mean they’re not really sold on them in their professional lives too? Do they tend to prescribe name brands when they shouldn’t? And how much does this cost all of us?

Originally posted here:  

Doctors Aren’t Really Very Smart About Buying Generics

Posted in FF, GE, LG, ONA, Uncategorized, Venta, Vintage | Tagged , , , , , , , | Comments Off on Doctors Aren’t Really Very Smart About Buying Generics